Medical/Pharmaceuticals
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition
AGC Biologics Now Provides End-to-End Cell and Gene Therapy CDMO Services SEATTLE, Oct. 28, 2020 /PRNewswire/ -- After its parent company AGC Inc. acquired 100% of the shares of MolMed S.p.A. onSeptember 30, 2020, AGC Biologics announced that MolMed's entity name has been changed to AGC Biologic...
2020-10-28 07:00
2251
Passive Immune Prophylaxis preventing COVID-19 with 'Acellular-Convalescent Plasma' (A-CP): a new technology introduced by Regen Lab®
Convalescent Plasma (CP), also called Passive Antibody Therapy for the treatment of COVID-19 infected patients was approved by the US-FDA on August 23, 2020! LAUSANNE, Switzerland, Oct. 27, 2020 /PRNewswire/ -- This great news was based on a nationwide evaluation in 14 US medical institutions. A...
2020-10-27 22:36
1492
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history
- The Fund continues the proven "Project Focused Company" investment strategy for early-stage drug development candidates - In addition, the Fund continues to invest in late-stage clinical biopharmaceutical companies, medical device companies and diagnostic companies MUNICH and MONTREAL, Oct. 27...
2020-10-27 20:00
2557
Annual SEA Mental Health Forum finds partnerships, innovation, and access as key solutions to tackling positive correlation between mental illness and COVID-19
* Mental health conditions such as schizophrenia, depression and neurological disorders are exacerbated by the COVID-19 pandemic acrossSoutheast Asia markets * Utilization of telehealth and telepsychiatry, home delivery of medications, enhanced training support on primary level and advancement...
2020-10-27 16:23
4629
Ratchaphruek Hospital Achieves GHA's COVID-19 Certification of Conformance for Medical Travel
WEST PALM BEACH, Florida, Oct. 27, 2020 /PRNewswire/ -- Ratchaphruek Hospital ( https://rph.co.th/en/), a top destination for medical travelers to Thailand, is the second hospital inThailand and the third hospital in the world to be awarded Global Healthcare Accreditation'sCertification of Conform...
2020-10-27 16:00
1974
Cytiva strengthens support to diagnostics industry with new labs, services and supply chain enhancements
* Now offering Cytiva Diagnostic Services, new diagnostic test development and support service virtually or at new lab, for point-of-care diagnostic developers to increase speed to market of new tests. * Supply chain enhancements include increasing inventory, investing in plants and expanding...
2020-10-27 16:00
3011
Sihuan Pharmaceutical (0460.HK) receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market
HONG KONG, Oct. 27, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460) is pleased announce that "Type A Botulinum Toxin for Injection" (Letybo 100U), a product exclusively distributed by Sihuan Pharmaceutical, has officially received the marketing approval from the Natio...
2020-10-27 10:42
6375
VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center
SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Renji Hospital, a top-ranked hospital inChinaaffiliated with the Shanghai Jiaotong University School of Medicine, has announced the launch of the world's first blockchain-enabled Intelligent Tumor Treatment Center on ...
2020-10-27 09:00
2659
Ortho's VITROS® SARS-CoV-2 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark
RARITAN, New Jersey, Oct. 27, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its new VITROS® SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for distribution throughout the EU. The company al...
2020-10-27 08:50
1239
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China
SUZHOU, China and ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...
2020-10-27 08:13
2378
Avidity Science™ Expands Biomedical Research Solutions Through Acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems
WATERFORD, Wisconsin, Oct. 27, 2020 /PRNewswire/ -- Today, Avidity Science announces significant steps in expanding its global leadership in biomedical research solutions via the acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems. These investments expand Av...
2020-10-27 08:00
2674
Drawbridge Health Announces Partnerships to Fuel Expansion in Japan
MENLO PARK, Calif., Oct. 27, 2020 /PRNewswire/ -- Drawbridge Health, a healthcare technology company redefining the blood draw experience for both patients and healthcare providers, today announced a further investment from Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") as w...
2020-10-27 08:00
1648
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1)
* CStone to out-license to EQRx exclusive rights to two late-stage immuno-oncology assets for development and commercialization outside ofGreater China * Agreement provides a pathway to bring CStone's sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1) to global patient communities by partnering ...
2020-10-27 07:23
3515
Tegra Medical Announces Expansion in Europe and Asia
End-to-end contract manufacturing of medical devices to be extended to nine locations FRANKLIN, Massachusetts, Oct. 27, 2020 /PRNewswire/ -- Tegra Medical, a leading contract manufacturer of medical devices and a member of SFS, which is headquartered in Heerbrugg Switzerland, today announced it ...
2020-10-27 01:42
1832
Getinge launches NICCI - the latest innovation in Advanced Hemodynamic Monitoring
- NICCI is Getinge's latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure GOTHENBURG, Sweden, Oct. 26, 2020 /PRNewswire/ -- Blood pressure is one of the most...
2020-10-26 21:34
3590
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus
HYDERABAD, India, Oct. 26, 2020 /PRNewswire/ -- Sai Life Sciences, one of
India's fastest growing Contract Research, Development & Manufacturing
Organizations
2020-10-26 16:35
2192
RhoVac Participates in BIO Europe Digital
LUND, Sweden, Oct. 26, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that it is participating this week in the partnering event BIO Europe 2020 Digital. This week the digital version of the massive pharmaceutical partnering conference BIO Europe is held with participation from RhoVac...
2020-10-26 16:26
1499
Article on RhoVac's Phase I/II study to be published in November
LUND, Sweden, Oct. 26, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that the publication of the article on RhoVac's Phase I/II study is set to be published in November. As previously disclosed, the article elaborating on the results of RhoVac's Phase I/II study in prostate cancer in...
2020-10-26 15:51
1433
Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies
MELBOURNE, Australia, Oct. 26, 2020 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters:Tokyo, CEO: Haruo Naito, "Eisai") and Cogstate, Ltd. (Headquarters:Melbourne, Australia and New Haven, USA, CEO: Brad O'Connor, "Cogstate") announced today that the companies have entered into a collaboration where...
2020-10-26 08:37
1931
Singapore Clinicians and Scientists Achieve Big Leap in Early Diagnosis of Gastric Cancer Through the Development of Non-Invasive Blood-based Test
SINGAPORE, Oct. 23, 2020 /PRNewswire/ -- After eight years of discovery research, product development and clinical validation involving 5,248 subjects fromSingapore and South Korea, a team of clinicians and scientists from Singapore has developed a non-invasive blood-based diagnostic test for gas...
2020-10-23 13:15
2608
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7433
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
6834
